LRMR icon

Larimar Therapeutics
LRMR

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$13
270% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Oppenheimer
Oppenheimer
Andreas Argyrides
0% 1-yr LRMR win rate
2 Oct ‘25 2 months ago
Wedbush
Wedbush
Laura Chico
100% 1-yr LRMR win rate
30 Sep ‘25 2 months ago
Baird
Baird
Joel Beatty
100% 1-yr LRMR win rate
30 Sep ‘25 2 months ago